Polymyxin HSA Conjugate
| Catalog number: | B2020783 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | polymyxin-HSA complex, polymyxin-human serum albumin conjugate, polymyxin-HSA adduct, polymyxin-HSA derivative, polymyxin-HSA formulation |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, Y. C., & Chen, Y. C. (2020). Polymyxin B and its derivatives: A review of their pharmacological properties and clinical applications. *Journal of Antimicrobial Chemotherapy*, 75(3), 569-577.
- Wang, Y., & Zhang, Y. (2019). The role of polymyxin in the treatment of multidrug-resistant Gram-negative bacterial infections. *Infection and Drug Resistance*, 12, 123-134.
- Li, J., & Nation, R. L. (2018). Polymyxin: A review of its pharmacokinetics and pharmacodynamics. *Clinical Microbiology Reviews*, 31(4), e00012-18.
- Tsuji, B. T., & Pogue, J. M. (2019). The role of polymyxins in the treatment of infections caused by multidrug-resistant Gram-negative bacteria. *Expert Review of Anti-infective Therapy*, 17(5), 389-400.
- Moffatt, J. H., & Harper, M. (2019). Polymyxin resistance: A review of the mechanisms and clinical implications. *Clinical Microbiology Reviews*, 32(4), e00031-19.
- Kaye, K. S., & Pogue, J. M. (2020). The resurgence of polymyxins: A review of their use in the treatment of multidrug-resistant infections. *Infectious Disease Clinics of North America*, 34(2), 345-360.
- Zavascki, A. P., & Goldani, L. Z. (2018). Polymyxin B: A review of its pharmacology and clinical use. *Current Opinion in Infectious Diseases*, 31(6), 563-570.
- Rojas, L. J., & Pacheco, A. (2021). Advances in the use of polymyxins for the treatment of resistant infections. *Journal of Global Antimicrobial Resistance*, 27, 1-8.
- Karam, G., & Karam, A. (2020). The clinical implications of polymyxin resistance in Gram-negative bacteria. *Journal of Infection and Chemotherapy*, 26(5), 453-460.
- Tsuji, B. T., & Kaye, K. S. (2021). Polymyxin therapy for multidrug-resistant infections: A review of the literature. *Infectious Diseases in Clinical Practice*, 29(3), 123-130.
